Cases & Deals

Isis expands patent portfolio related to bicyclic nucleic acids (BNAs) and antisense oligomers containing BNAs

Clients Isis Pharmaceuticals, Inc.

Jones Day represents Isis Pharmaceuticals, Inc. with the management and development of a patent portfolio related to bicyclic nucleic acids (BNAs) and antisense oligomers containing BNAs.